Nature Publication Highlights the Benefits of Tropis® Intradermal When Used to Administer a First-in-Class Self-Amplifying mRNA Vaccine

GOLDEN, Colo.--(BUSINESS WIRE)--Nature study shows delivery of a novel self-amplifying mRNA-based vaccine with Tropis directly into the dermis significantly boosts immune responses.